Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00871312 · ClinicalTrials.gov registry record · NA
Evaluation of Topical Wound Oxygen (two2) Therapy
A NA study, sponsored by AOTI.
- Terminated
- Registry status
- NA
- Development phase
- 21
- Enrollment target
NCT00871312: Clinical Trial NA study, sponsored by AOTI.
NCT00871312 is a NA study that was terminated before completion, run by AOTI. The registered enrollment target is 21 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00871312, a NA study, was terminated before completion, sponsored by AOTI.
- TERMINATED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the efficacy of the Topical Wound Oxygen (two2) therapy system on the healing of diabetic lower extremity ulcers.
Interventions
- DEVICE Topical wound oxygen therapy
- DEVICE Topical wound oxygen Placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2007-05 |
| Est. Completion | 2009-12 |
| Phase | NA |
Why NCT00871312 stopped before completion
NCT00871312 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 21 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Topical wound oxygen therapy is the first listed.
NCT00871312 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00871312 about?
NCT00871312 is a clinical study titled "Evaluation of Topical Wound Oxygen (two2) Therapy". The purpose of this study is to evaluate the efficacy of the Topical Wound Oxygen (two2) therapy system on the healing of diabetic lower extremity ulcers.
What is the current status of trial NCT00871312?
This trial is currently terminated. It is a NA study. The enrollment target is 21 participants. The study started on 2007-05. Estimated completion is 2009-12.
What interventions are being tested in trial NCT00871312?
The interventions under investigation include: Topical wound oxygen therapy (DEVICE), Topical wound oxygen Placebo (DEVICE).
Who is sponsoring clinical trial NCT00871312?
This trial is sponsored by AOTI, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00871312's enrollment target sits among peer trials
21 1762nd of 2000 higher than 233 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02447874 · 21 participants · Phase 1
Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease
- NCT03826992 · 21 participants · Phase 1
Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
- NCT04107077 · 21 participants · Phase 2
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
- NCT04158635 · 21 participants · Phase 1
Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia